Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 9869208, 5 pages
http://dx.doi.org/10.1155/2016/9869208
Review Article

The Emerging Role of MicroRNA-155 in Cardiovascular Diseases

1Laboratory of Immunology, Shanghai Xuhui Central Hospital/Shanghai Zhongshan-Xuhui Hospital, Fudan University/Shanghai Clinical Research Center, Chinese Academy of Sciences, 966 Middle Huaihai Road, Shanghai 200031, China
2Department of Rehabilitation, Shanghai Xuhui Central Hospital/Shanghai Zhongshan-Xuhui Hospital, Fudan University/Shanghai Clinical Research Center, Chinese Academy of Sciences, 966 Middle Huaihai Road, Shanghai 200031, China
3Clinical Laboratory, Shanghai Xuhui Central Hospital/Shanghai Zhongshan-Xuhui Hospital, Fudan University/Shanghai Clinical Research Center, Chinese Academy of Sciences, 966 Middle Huaihai Road, Shanghai 200031, China
4School of Life Sciences, Shanghai University, 99 Shangda Road, Shanghai 200444, China

Received 27 June 2016; Revised 20 September 2016; Accepted 29 September 2016

Academic Editor: Xinli Li

Copyright © 2016 Richard Y. Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Naghavi, H. Wang, R. Lozano R et al., “Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 385, no. 9963, pp. 117–171, 2015. View at Publisher · View at Google Scholar
  2. R. C. Lee, R. L. Feinbaum, and V. Ambros, “The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14,” Cell, vol. 75, no. 5, pp. 843–854, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Wightman, I. Ha, and G. Ruvkun, “Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans,” Cell, vol. 75, no. 5, pp. 855–862, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Gao and J. Chen, “Non-coding RNAs mediate cardiac remodeling and regeneration,” Journal of Shanghai University, vol. 22, no. 3, pp. 302–309, 2016. View at Google Scholar
  6. J. Wang, J. Gao, and W. Ding, “Non—coding RNAs and myocardial remodeling,” Journal of Shanghai University, vol. 22, no. 3, pp. 310–317, 2016. View at Google Scholar
  7. H. Wang, Y. Bei, S. Shen et al., “miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2,” Journal of Molecular and Cellular Cardiology, vol. 94, pp. 43–53, 2016. View at Publisher · View at Google Scholar
  8. H. Liu, H. Wang, J. Shi et al., “Circulating miR-21-3-p as biomarkers for sepsis-induced cardiomyopathy,” Journal of Shanghai University, vol. 22, no. 3, pp. 366–370, 2016. View at Google Scholar
  9. L. Tao, Y. Bei, P. Chen et al., “Crucial role of miR-433 in regulating cardiac fibrosis,” Theranostics, vol. 6, no. 12, pp. 2068–2083, 2016. View at Publisher · View at Google Scholar
  10. M. Abdellatif, “Differential expression of microRNAs in different disease states,” Circulation Research, vol. 110, no. 4, pp. 638–650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Liu, J. Xiao, H. Zhu et al., “MiR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling,” Cell Metabolism, vol. 21, no. 4, pp. 584–595, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. P. S. Eis, W. Tam, L. Sun et al., “Accumulation of miR-155 and BIC RNA in human B cell lymphomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3627–3632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Metzler, M. Wilda, K. Busch, S. Viehmann, and A. Borkhardt, “High expression of precursor microRNA-155/BIC RNA in children with burkitt lymphoma,” Genes Chromosomes and Cancer, vol. 39, no. 2, pp. 167–169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Chen, T. Ma, C. Huang, T. Hu, and J. Li, “The pivotal role of microRNA-155 in the control of cancer,” Journal of Cellular Physiology, vol. 229, no. 5, pp. 545–550, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Faraoni, F. R. Antonetti, J. Cardone, and E. Bonmassar, “miR-155 gene: a typical multifunctional microRNA,” Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1792, no. 6, pp. 497–505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. T. S. Elton, H. Selemon, S. M. Elton, and N. L. Parinandi, “Regulation of the MIR155 host gene in physiological and pathological processes,” Gene, vol. 532, no. 1, pp. 1–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Sethupathy, C. Borel, M. Gagnebin et al., “Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes,” The American Journal of Human Genetics, vol. 81, no. 2, pp. 405–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. W. Thompson, J. A. Curci, T. L. Ennis, D. Mao, M. B. Pagano, and C. T. N. Pham, “Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds,” Annals of the New York Academy of Sciences, vol. 1085, pp. 59–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. N. D. Wong, “Epidemiological studies of CHD and the evolution of preventive cardiology,” Nature Reviews Cardiology, vol. 11, no. 5, pp. 276–289, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Matsumoto, Y. Sakata, D. Nakatani et al., “A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction,” Biochemical and Biophysical Research Communications, vol. 427, no. 2, pp. 280–284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Xie, P. Li, Z. Wang et al., “Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway,” Cardiovascular Therapeutics, vol. 32, no. 6, pp. 276–282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. F.-J. Tian, L.-N. An, G.-K. Wang et al., “Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis,” Cardiovascular Research, vol. 103, no. 1, pp. 100–110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. U. Eisenhardt, J. B. W. Weiss, C. Smolka et al., “MicroRNA-155 aggravates ischemia–reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burst,” Basic Research in Cardiology, vol. 110, no. 3, pp. 1–16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Nazari-Jahantigh, Y. Wei, H. Noels et al., “MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages,” The Journal of Clinical Investigation, vol. 122, no. 11, pp. 4190–4202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Yao, Y. Ma, Y. Du et al., “The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome,” Cellular & Molecular Immunology, vol. 8, no. 6, pp. 486–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Zidar, E. Boštjančič, D. Glavač, and D. Štajer, “MicroRNAs, innate immunity and ventricular rupture in human myocardial infarction,” Disease Markers, vol. 31, no. 5, pp. 259–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Wang, L.-D. Dong, X.-B. Meng, Q. Shi, and W.-Y. Sun, “Unique MicroRNA signatures associated with early coronary atherosclerotic plaques,” Biochemical and Biophysical Research Communications, vol. 464, no. 2, pp. 574–579, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Hao, X.-G. Wang, J.-D. Cheng et al., “The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human atherosclerotic coronary artery,” Cardiovascular Pathology, vol. 23, no. 4, pp. 217–223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. G.-F. Zhu, L.-X. Yang, R.-W. Guo et al., “microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score,” Coronary Artery Disease, vol. 25, no. 4, pp. 304–310, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Li, D. Kong, H. Chen et al., “MiR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1,” Scientific Reports, vol. 6, Article ID 21789, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Zhu, T. Chen, L. Yang et al., “Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10,” PLoS ONE, vol. 7, no. 11, Article ID e46551, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Y. Cao, T. S. Amand, M. D. Ford et al., “The murine angiotensin II-induced abdominal aortic aneurysm model: rupture risk and inflammatory progression patterns,” Frontiers in Pharmacology, vol. 1, no. 9, 2010. View at Publisher · View at Google Scholar
  33. K. C. Kent, “Abdominal aortic aneurysms,” The New England Journal of Medicine, vol. 371, no. 22, pp. 2101–2108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Y. Cao, T. St Amand, X. Z. Li et al., “Prostaglandin receptor EP4 in abdominal aortic aneurysms,” The American Journal of Pathology, vol. 181, no. 1, pp. 313–321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Biros, C. S. Moran, Y. Wang, P. J. Walker, J. Cardinal, and J. Golledge, “microRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155,” Clinical Science, vol. 126, no. 11, pp. 795–803, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Kin, S. Miyagawa, S. Fukushima et al., “Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm,” Journal of the American Heart Association, vol. 1, no. 5, Article ID e000745, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. J. V. McMurray and M. A. Pfeffer, “Heart failure,” The Lancet, vol. 365, no. 9474, pp. 1877–1889, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. H. M. Krumholz, Y.-T. Chen, Y. Wang, V. Vaccarino, M. J. Radford, and R. I. Horwitz, “Predictors of readmission among elderly survivors of admission with heart failure,” American Heart Journal, vol. 139, no. 1, pp. 72–77, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Ikitimur, H. A. Cakmak, E. Coskunpinar, H. A. Barman, and V. A. Vural, “The relationship between circulating microRNAs and left ventricular mass in symptomatic heart failure patients with systolic dysfunction,” Kardiologia Polska, vol. 73, no. 9, pp. 740–746, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Z. Marques, D. Vizi, O. Khammy, J. A. Mariani, and D. M. Kaye, “The transcardiac gradient of cardio-microRNAs in the failing heart,” European Journal of Heart Failure, vol. 18, no. 8, pp. 1000–1008, 2016. View at Publisher · View at Google Scholar
  41. W. He, H. Huang, Q. Xie et al., “MiR-155 knockout in fibroblasts improves cardiac remodeling by targeting tumor protein p53-inducible nuclear protein 1,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 21, no. 4, pp. 423–435, 2016. View at Publisher · View at Google Scholar
  42. G. Delice, Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 2nd edition, 2003.
  43. T. H. Marwick, “Diabetic heart disease,” Postgraduate Medical Journal, vol. 84, no. 990, pp. 188–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Lamblin, M. Fertin, P. de Groote, and C. Bauters, “Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus,” Journal of Cardiovascular Medicine, vol. 13, no. 6, pp. 353–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Costantino, F. Paneni, T. F. Lüscher, and F. Cosentino, “MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart,” European Heart Journal, vol. 37, no. 6, pp. 572–576, 2016. View at Publisher · View at Google Scholar
  46. R. Kishore, S. K. Verma, A. R. Mackie et al., “Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts,” PLoS ONE, vol. 8, no. 4, Article ID e60161, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Zhu, D. Zhang, S. Chen et al., “Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration,” Atherosclerosis, vol. 215, no. 2, pp. 286–293, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M. F. Corsten, A. Papageorgiou, W. Verhesen et al., “MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis,” Circulation Research, vol. 111, no. 4, pp. 415–425, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Ottosen, T. B. Parsley, L. Yang et al., “In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 1, pp. 599–608, 2015. View at Publisher · View at Google Scholar · View at Scopus